Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prospective evaluation of rotating chemotherapy in advanced breast cancer. An Eastern Cooperative Oncology Group Trial.

× No keyword cloud information.

10 in total

Review 1. Current status of chemotherapy of breast cancer.

Authors: A Coates
Journal: Drugs Date: 1984-08 Impact factor: 9.546

2. Haematological toxicity: a marker of adjuvant chemotherapy efficacy in stage II and III breast cancer.

Authors: T Saarto; C Blomqvist; P Rissanen; A Auvinen; I Elomaa
Journal: Br J Cancer Date: 1997 Impact factor: 7.640

3. Short term high density systemic therapy for metastatic breast cancer.

Authors: D C Tormey; J C Kline; M Palta; T E Davis; R R Love; P P Carbone
Journal: Breast Cancer Res Treat Date: 1985 Impact factor: 4.872

4. A randomized trial of two regimens of cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone in advanced breast cancer.

Authors: J Carmo-Pereira; F O Costa; E Henriques; V Carvalho
Journal: Cancer Chemother Pharmacol Date: 1986 Impact factor: 3.333

Review 5. Postmenopausal breast cancer. Drug therapy in the 1990s.

Authors: C I Falkson; G Falkson; H C Falkson
Journal: Drugs Aging Date: 1993 Mar-Apr Impact factor: 3.923

Review 6. Chemotherapy of breast cancer.

Authors: L S Perlow; J F Holland
Journal: Med Oncol Tumor Pharmacother Date: 1984

7. Long-term tamoxifen adjuvant therapy in node-positive breast cancer: a metabolic and pilot clinical study.

Authors: D C Tormey; V C Jordan
Journal: Breast Cancer Res Treat Date: 1984 Impact factor: 4.872

8. CMF vs alternating CMF/EV in the adjuvant treatment of operable breast cancer. A single centre randomised clinical trial (Naples GUN-3 study).

Authors: S De Placido; F Perrone; C Carlomagno; A Morabito; C Pagliarulo; R Lauria; A Marinelli; M De Laurentiis; E Varriale; G Petrella
Journal: Br J Cancer Date: 1995-06 Impact factor: 7.640

9. Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMF.

Authors: P Poikonen; T Saarto; J Lundin; H Joensuu; C Blomqvist
Journal: Br J Cancer Date: 1999-08 Impact factor: 7.640

Review 10. Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy.

Authors: Bruce D Keith
Journal: BMC Cancer Date: 2008-03-28 Impact factor: 4.430

10 in total